Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Richard Duke
AddedMar 31, 2024
UpdatedMay 31, 2026
Richard Duke

Richard Duke

Founder, Colorado Institute for Drug Device and Diagnostic Development

CrunchbaseLinkedIn

Richard Duke's Career

Colorado Institute for Drug Device and Diagnostic Development
Colorado Institute for Drug Device and Diagnostic Development

Aurora, CO, US

Founder
Aurora Oncology
Aurora Oncology

Aurora, CO, US

Board Member· Board
MenoGeniX
MenoGeniX

Aurora, CO, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Richard Duke's Career

Colorado Institute for Drug Device and Diagnostic Development
Colorado Institute for Drug Device and Diagnostic Development
NonprofitNonprofit112004Aurora, CO, US
Founder

Leadership at Colorado Institute for Drug Device and Diagnostic Development

Steve OrndorffSteve OrndorffBoard Member
Ginny OrndorffGinny OrndorffBoard Member

Similar to Colorado Institute for Drug Device and Diagnostic Development

CqdmCqdmMontreal, Quebec, CADrug Discoveryest. 2008CqdmMontreal, Quebec, CA · est. 2008

CQDM: A scientific organization uniting academia, biotech, and pharma for drug discovery.

Nonprofit20
CtipCtipLos Angeles, CA, USMedical Devicesest. 2011CtipLos Angeles, CA, US · est. 2011

CTIP: Accelerating pediatric medical devices to market, driven by innovation and demand.

Nonprofit9
Society to Improve Diagnosis in MedicineSociety to Improve Diagnosis in MedicineEvanston, IL, USAdvocacy, Healthcareest. 2011Society to Improve Diagnosis in MedicineEvanston, IL, US · est. 2011

Founded in 2011, Society To Improve Diagnosis In Medicine, Inc. is a non-profit promoting safer healthcare.

Nonprofit25
Copic Medical FoundationCopic Medical FoundationDenver, CO, USHealthcare, Patient Safetyest. 1981Copic Medical FoundationDenver, CO, US · est. 1981

Denver-based COPIC Medical Foundation enhances healthcare outcomes, patient safety, and care quality.

Nonprofit50
Aurora Oncology
Aurora Oncology
Angel$250k82011Aurora, CO, US
Board Member· Board

Leadership at Aurora Oncology

L. Michael GlodéL. Michael GlodéCo-Founder
Thomas FlaigThomas FlaigCo-Founder

Similar to Aurora Oncology

Onc.AIOnc.AISan Carlos, CA, USOncology Softwareest. 2020Onc.AISan Carlos, CA, US · est. 2020

Creating precision oncology software for clinical use, with a focus on physician-centered products.

Series A · $31M30
Auron TherapeuticsAuron TherapeuticsWellesley, MA, USCancer Therapiesest. 2018Auron TherapeuticsWellesley, MA, US · est. 2018

Auron Therapeutics: Pioneering cell transformation therapies for cancer treatment.

Series A · $61.4M28
OnKure TherapeuticsOnKure TherapeuticsLongmont, CO, USCancer Therapiesest. 2011OnKure TherapeuticsLongmont, CO, US · est. 2011

OnKure, Inc., a Boulder-based biotech firm, specializes in discovering and developing cancer epigenetic therapies.

Public · $121.5M39
Aurion BiotechAurion BiotechSeattle, WA, USBiotech, Therapiesest. 2021Aurion BiotechSeattle, WA, US · est. 2021

Aurion Biotech: Clinical-stage biotech firm pioneering advanced therapies to cure blindness.

Late Stage Private · $120M55
MenoGeniX
MenoGeniX
Pre-Seed$1.1M52010Aurora, CO, US
Board Member· Board

Leadership at MenoGeniX

Douglas FarrarDouglas FarrarCo-Founder
Debra M. DukeDebra M. DukeCo-Founder

Similar to MenoGeniX

JangoBioJangoBioFitchburg, WI, USStem Cell Therapiesest. 2015JangoBioFitchburg, WI, US · est. 2015

JangoBio: A biotech firm innovating regenerative therapies for age-related hormone imbalances.

Seed · $2.5M15

Richard Duke's Similar Executives & Operators

Shinya KatanozakaShinya KatanozakaBoard Member · ANA HoldingsYuji HirakoYuji HirakoBoard Member · ANA HoldingsKoji ShibataKoji ShibataCEO · ANA HoldingsOsamu ShinobeOsamu ShinobeBoard Member · ANA HoldingsIzumi KobayashiIzumi KobayashiBoard Member · ANA HoldingsShinichiro ItoShinichiro ItoBoard Member · ANA HoldingsNaoto TakadaNaoto TakadaBoard Member · ANA HoldingsAkira FukaboriAkira FukaboriFounder · ANA Holdings

People Similar to Richard Duke

Oliver PappOliver PappFounder · Aurora TechnologySpencer GuthrieSpencer GuthrieFounder & CEO · AttralusRobert B.Robert B.Board Member · Aurora PharmaceuticalChristopher HopperChristopher HopperCo-Founder · Aurora Solar